VAERS reports by lot

Moderna COVID-19 lot 026LZOA: VAERS reports

27 VAERS reports list lot 026LZOA as a Moderna COVID-19 vaccine, received between 2020-12-30 and 2022-01-31. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
27
Reports
4%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3325%
General / Systemic (non-local)3224%
Neurological1814%
Gastrointestinal1411%
Respiratory118%
Musculoskeletal118%
Cardiac / Cardiovascular65%
Allergic / Anaphylactic32%
Dermatological (non-injection-site)32%
Autoimmune / Immune-mediated11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

New Jersey5
Georgia3
Michigan3
Illinois2
Massachusetts2
Kentucky1
Connecticut1
Virginia1
California1
Florida1
New York1
Iowa1

Reports by month received

2020-121
2021-0114
2021-026
2021-032
2021-081
2021-091
2021-111
2022-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.